Adaptive Biotechnologies CorporationADPTNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank38
3Y CAGR+17.4%
5Y CAGR-34.3%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+17.4%/yr
vs -48.6%/yr prior
5Y CAGR
-34.3%/yr
Recent acceleration
Acceleration
+65.9pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 9.65 | +87.0% |
| 2024 | 5.16 | +18.6% |
| 2023 | 4.35 | -27.1% |
| 2022 | 5.97 | -76.4% |
| 2021 | 25.34 | -67.8% |
| 2020 | 78.71 | +82.9% |
| 2019 | 43.03 | -49.6% |
| 2018 | 85.43 | -30.5% |
| 2017 | 122.90 | - |